Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province, China: An Open-labeled, Ambidirectional Cohort Study

NCT04817917 is registered in ClinicalTrials.gov with Zhejiang Provincial Center for Disease Control and Prevention as lead sponsor.

NCT NCT04817917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04817917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province, China: An Open-labeled, Ambidirectional Cohort Study
Lead sponsor
Zhejiang Provincial Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2021
Completion date
June 30, 2023
Enrollment
712 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis, vaccine preventable disease, vaccine reaction